Multiple Sclerosis : : Diagnosis and Treatment / / Víctor M. Rivera.

Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecular and immunological mechanisms, which eventually lead to relapsing and progressive clinical forms and a constellation of clinical manifestations. Along with the progress in knowledge, disease-modify...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (192 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993562233304498
ctrlnum (CKB)4920000001372175
(NjHacI)994920000001372175
(EXLCZ)994920000001372175
collection bib_alma
record_format marc
spelling Rivera, Víctor M, author.
Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera.
Multiple Sclerosis
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
1 online resource (192 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecular and immunological mechanisms, which eventually lead to relapsing and progressive clinical forms and a constellation of clinical manifestations. Along with the progress in knowledge, disease-modifying treatments and new therapeutic molecules have made an impact on the prognosis of the disease. Essential in the diagnostic identification process of MS is the differentiation of this major demyelinating disease with other inflammatory CNS disorders, including Neuromyelitis Optica and MOG antibody disease. MS is more prevalent in women; therefore, pregnancy and post-partum hormonal and immunological changes typically affect the clinical behavior of the disease. This Special Issue of Biomedicines addresses recent advances in the mechanistic genetic and immunological processes of MS, opening more options to future studies and to the consideration of further therapeutic possibilities. The issue discusses the application of modern therapies, including monoclonal antibodies, some still in the process of complete development, and the current strategies managing progressive MS. The aim of this issue is to stimulate basic and clinical research and promote observations on the ever-expanding and complex field of MS. Advancement in the understanding of the mechanisms and the clinical characterizations of this disease should result in improved therapeutic outcomes that reduce neurological and cognitive disability commonly associated with progressive disease.
Medicine.
3-0365-3097-5
language English
format eBook
author Rivera, Víctor M,
spellingShingle Rivera, Víctor M,
Multiple Sclerosis : Diagnosis and Treatment /
author_facet Rivera, Víctor M,
author_variant v m r vm vmr
author_role VerfasserIn
author_sort Rivera, Víctor M,
title Multiple Sclerosis : Diagnosis and Treatment /
title_sub Diagnosis and Treatment /
title_full Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera.
title_fullStr Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera.
title_full_unstemmed Multiple Sclerosis : Diagnosis and Treatment / Víctor M. Rivera.
title_auth Multiple Sclerosis : Diagnosis and Treatment /
title_alt Multiple Sclerosis
title_new Multiple Sclerosis :
title_sort multiple sclerosis : diagnosis and treatment /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (192 pages)
isbn 3-0365-3097-5
callnumber-first R - Medicine
callnumber-subject R - General Medicine
callnumber-label R117
callnumber-sort R 3117 R584 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 610 - Medicine & health
dewey-full 610
dewey-sort 3610
dewey-raw 610
dewey-search 610
work_keys_str_mv AT riveravictorm multiplesclerosisdiagnosisandtreatment
AT riveravictorm multiplesclerosis
status_str n
ids_txt_mv (CKB)4920000001372175
(NjHacI)994920000001372175
(EXLCZ)994920000001372175
carrierType_str_mv cr
is_hierarchy_title Multiple Sclerosis : Diagnosis and Treatment /
_version_ 1764992751686909952
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02516nam a2200289 i 4500</leader><controlfield tag="001">993562233304498</controlfield><controlfield tag="005">20230225162900.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230225s2022 sz o 000 0 eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/books978-3-0365-3097-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372175</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R117</subfield><subfield code="b">.R584 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rivera, Víctor M,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multiple Sclerosis :</subfield><subfield code="b">Diagnosis and Treatment /</subfield><subfield code="c">Víctor M. Rivera.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Multiple Sclerosis </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (192 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecular and immunological mechanisms, which eventually lead to relapsing and progressive clinical forms and a constellation of clinical manifestations. Along with the progress in knowledge, disease-modifying treatments and new therapeutic molecules have made an impact on the prognosis of the disease. Essential in the diagnostic identification process of MS is the differentiation of this major demyelinating disease with other inflammatory CNS disorders, including Neuromyelitis Optica and MOG antibody disease. MS is more prevalent in women; therefore, pregnancy and post-partum hormonal and immunological changes typically affect the clinical behavior of the disease. This Special Issue of Biomedicines addresses recent advances in the mechanistic genetic and immunological processes of MS, opening more options to future studies and to the consideration of further therapeutic possibilities. The issue discusses the application of modern therapies, including monoclonal antibodies, some still in the process of complete development, and the current strategies managing progressive MS. The aim of this issue is to stimulate basic and clinical research and promote observations on the ever-expanding and complex field of MS. Advancement in the understanding of the mechanisms and the clinical characterizations of this disease should result in improved therapeutic outcomes that reduce neurological and cognitive disability commonly associated with progressive disease.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3097-5</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-01 01:53:44 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338185000004498&amp;Force_direct=true</subfield><subfield code="Z">5338185000004498</subfield><subfield code="8">5338185000004498</subfield></datafield></record></collection>